Fig. 6From: Baseline autoantibody profile in rheumatoid arthritis is associated with early treatment response but not long-term outcomesSummary of results. Colours of the antibodies indicate diversity in antigenic targets, and structures indicate diversity in the isotype usage. A broad baseline profile (left) is favourable for early response, but has no association with long-term outcomes like drug-free remission, as compared to a less broad baseline profile (right). The association with the breadth of the baseline profile diminishes with timeBack to article page